• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?

作者信息

Raza Karim, Filer Andrew

机构信息

School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK Department of Rheumatology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.

School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

出版信息

Ann Rheum Dis. 2015 May;74(5):793-4. doi: 10.1136/annrheumdis-2014-206993. Epub 2015 Mar 10.

DOI:10.1136/annrheumdis-2014-206993
PMID:25757869
Abstract
摘要

相似文献

1
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?类风湿关节炎的治疗机会窗：它会关闭吗？
Ann Rheum Dis. 2015 May;74(5):793-4. doi: 10.1136/annrheumdis-2014-206993. Epub 2015 Mar 10.
2
Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts.评估类风湿关节炎症状持续时间与持续性之间的关系：是否存在机会之窗？莱顿早期关节炎诊所和 ESPOIR 队列的研究结果。
Ann Rheum Dis. 2015 May;74(5):806-12. doi: 10.1136/annrheumdis-2014-206047. Epub 2015 Jan 5.
3
The importance of early treatment for the prognosis of rheumatoid arthritis.类风湿关节炎预后早期治疗的重要性。
Swiss Med Wkly. 2013 Sep 19;143:w13865. doi: 10.4414/smw.2013.13865. eCollection 2013.
4
When is it not ethical to withhold treatment for rheumatoid arthritis?在什么时候停止对类风湿性关节炎的治疗是不符合伦理道德的？
Ann Rheum Dis. 2014 May;73(5):e25. doi: 10.1136/annrheumdis-2013-205033. Epub 2013 Dec 24.
5
Treating rheumatoid arthritis early: a window of opportunity?早期治疗类风湿关节炎：一个机会之窗？
Arthritis Rheum. 2002 Feb;46(2):283-5. doi: 10.1002/art.10092.
6
Understanding the window of opportunity concept in early rheumatoid arthritis.理解早期类风湿关节炎中的机会窗概念。
Arthritis Rheum. 2003 Jul;48(7):1771-4. doi: 10.1002/art.11156.
7
Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials.早期类风湿关节炎治疗窗口时机：临床试验中疾病持续时间定义的建议。
Ann Rheum Dis. 2012 Dec;71(12):1921-3. doi: 10.1136/annrheumdis-2012-201893. Epub 2012 Aug 31.
8
Early aggressive therapy in rheumatoid arthritis: a 'window of opportunity'?类风湿关节炎的早期积极治疗：一个“机会窗口”？
Nat Clin Pract Rheumatol. 2005 Nov;1(1):2-3. doi: 10.1038/ncprheum0015.
9
Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.类风湿关节炎生物制剂治疗患者在传统合成改善病情抗风湿药物间转换的经济负担及治疗模式
Clin Ther. 2016 May;38(5):1205-16. doi: 10.1016/j.clinthera.2016.03.013. Epub 2016 Apr 2.
10
Advances in rheumatoid arthritis.类风湿关节炎的研究进展。
Med J Aust. 2017 Mar 20;206(5):221-224. doi: 10.5694/mja16.01287.

引用本文的文献

1
Should Joint Deformity, which is More Common Than Swelling or Tenderness, be Assessed in all Rheumatoid Arthritis Patients and Databases?在所有类风湿性关节炎患者及数据库中，是否都应评估比肿胀或压痛更常见的关节畸形？
ACR Open Rheumatol. 2025 May;7(5):e70025. doi: 10.1002/acr2.70025.
2
Anti-Rheumatic potential of biological DMARDS and protagonistic role of bio-markers in early detection and management of rheumatoid arthritis.生物性改善病情抗风湿药的抗风湿潜力及生物标志物在类风湿关节炎早期检测与管理中的主导作用。
Innate Immun. 2025 Jan-Dec;31:17534259251324820. doi: 10.1177/17534259251324820. Epub 2025 Mar 16.
3
T Cell Dysregulation in Rheumatoid Arthritis: from Genetic Susceptibility to Established Disease.
类风湿关节炎中的T细胞失调：从遗传易感性到疾病确诊
Curr Rheumatol Rep. 2025 Jan 25;27(1):14. doi: 10.1007/s11926-025-01180-1.
4
Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study.尽快！早期获得专业治疗可改善类风湿关节炎的长期预后：REAL 多中心观察性研究的数据。
Adv Rheumatol. 2023 Apr 24;63(1):17. doi: 10.1186/s42358-023-00301-7.
5
The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study.在接受阿巴西普治疗后达到持续缓解的早期类风湿关节炎患者的临床应答轨迹：AVERT-2 的亚分析，一项随机 IIIb 期研究。
Arthritis Res Ther. 2023 Apr 22;25(1):67. doi: 10.1186/s13075-023-03038-2.
6
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis.早期类风湿关节炎患者逐步降低剂量后使用阿巴西普加甲氨蝶呤的持续缓解及结局
Rheumatol Ther. 2023 Jun;10(3):707-727. doi: 10.1007/s40744-022-00519-9. Epub 2023 Mar 3.
7
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis.基线血清Ⅰ型胶原交联羧基末端肽水平可预测甲氨蝶呤初治、抗瓜氨酸化蛋白抗体阳性的早期类风湿关节炎患者对阿巴西普的治疗反应。
RMD Open. 2022 Dec;8(2). doi: 10.1136/rmdopen-2022-002683.
8
The value of ultrasound-defined tenosynovitis and synovitis in the prediction of persistent arthritis.超声定义腱鞘炎和滑膜炎对持续性关节炎的预测价值。
Rheumatology (Oxford). 2023 Mar 1;62(3):1057-1068. doi: 10.1093/rheumatology/keac199.
9
Total Hip Replacement in Patients with Rheumatoid Arthritis: Trends in Incidence and Complication Rates Over 35 Years.类风湿性关节炎患者的全髋关节置换术：35年间发病率和并发症发生率的趋势
Rheumatol Ther. 2022 Apr;9(2):565-580. doi: 10.1007/s40744-021-00414-9. Epub 2022 Jan 8.
10
Alternative care providers in rheumatoid arthritis patient care: a queueing and simulation analysis.类风湿性关节炎患者护理中的替代护理提供者：排队与模拟分析
Health Syst (Basingstoke). 2020 Jun 14;10(4):249-267. doi: 10.1080/20476965.2020.1771619. eCollection 2021.